Smart Agro - Limited

TASE:SMAG Stock Report

Market Cap: ₪6.8m

Smart Agro - Valuation

Is SMAG undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

1/6

Valuation Score 1/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Book vs Peers

  • Price-To-Book vs Industry

  • Price-To-Book vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of SMAG when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate SMAG's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate SMAG's fair value for valuation analysis.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for SMAG?

Key metric: As SMAG is unprofitable and pre-revenue we use its Price-To-Book Ratio for relative valuation analysis.

The above table shows the Price to Book ratio for SMAG. This is calculated by dividing SMAG's market cap by their current book value.
What is SMAG's PB Ratio?
PB Ratio0.2x
Book₪36.41m
Market Cap₪6.79m

Price to Book Ratio vs Peers

How does SMAG's PB Ratio compare to its peers?

The above table shows the PB ratio for SMAG vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PBEstimated GrowthMarket Cap
Peer Average0.8x
PLNT PlantArc Bio
0.5xn/a₪4.9m
HDST-M HBL - Hadasit Bio-Holdings
1.8xn/a₪5.2m
UNVO Univo Pharmaceuticals
0.2xn/a₪2.8m
EVGN Evogene
n/a37.4%₪32.5m
SMAG Smart Agro -
0.2xn/a₪6.8m

Price-To-Book vs Peers: SMAG is expensive based on its Price-To-Book Ratio (0.2x) compared to the peer average (0.1x).

Price to Book Ratio vs Industry

How does SMAG's PB Ratio compare vs other companies in the Asian Biotechs Industry?

10 CompaniesPrice / BookEstimated GrowthMarket Cap
Industry Avg.2.7x49.3%
SMAG Smart Agro -
 0.2xn/aUS$1.83m
SMAG 0.2xIndustry Avg. 2.7xNo. of Companies46PB0246810+
10 CompaniesEstimated GrowthMarket Cap
Industry Avg.2.7x49.3%
SMAG Smart Agro -
 0.2xn/aUS$1.83m
No more companies

Price-To-Book vs Industry: SMAG is good value based on its Price-To-Book Ratio (0.2x) compared to the Asian Biotechs industry average (2.7x).

Price to Book Ratio vs Fair Ratio

What is SMAG's PB Ratio compared to its Fair PB Ratio? This is the expected PB Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

SMAG PB Ratio vs Fair Ratio.
Fair Ratio
Current PB Ratio0.2x
Fair PB Ration/a

Price-To-Book vs Fair Ratio: Insufficient data to calculate SMAG's Price-To-Book Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.

Discover undervalued companies

Evogene

₪32.5m

Operates as a computational biology company.

EVGN

₪6.07

7D

-10.8%

1Y

-72.3%

Protalix BioTherapeutics

US$112.5m

A biopharmaceutical company, engages in the development, production, and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx plant cell-based protein expression system in the United States, Australia, Canada, Israel, Brazil, Russia, Turkey, and internationally.

PLX

US$7.33

7D

-0.1%

1Y

97.5%